GlassScriptPhysician profile
Jose Paul Loor
NPI 1982906723
$7,118.38
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $4,532 · 2021: $595 · 2022: $821 · 2023: $250 · 2024: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $3,050.00 | 2020 | |
| Tenex Health INC. | $1,085.92 | 2020 | |
| Horizon Therapeutics Plc | $832.27 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $554.92 | 2021-2024 | Nuzyra |
| Orthofix Medical, INC. | $549.03 | 2019-2022 | |
| Royal Biologics, INC. | $206.97 | 2021 | |
| Arthrosurface Incorporated | $180.29 | 2019 | |
| Nevro Corp. | $176.92 | 2022 | |
| Arteriocyte Medical Systems, INC. | $99.77 | 2019 | |
| Medtronic USA, INC. | $87.11 | 2019 | |
| Forte Bio-Pharma LLC | $76.99 | 2022 | |
| In2bones USA, LLC | $67.83 | 2020 | |
| Zimmer Biomet Holdings, INC. | $54.91 | 2022 | |
| Treace Medical Concepts, INC. | $40.60 | 2022 | |
| Sandoz INC. | $20.35 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $20.20 | 2022 | |
| Pfizer INC. | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Loor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.